GTO Pharmaceutical, LLC   Report issue

For profit Phase 4
Founded: Lewes DE United States (2018)

Organization Overview

First Clinical Trial
2018
NCT03682601
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

GTO Pharmaceutical, LLC

Active Ingredients

Drugs in Phase 4 Trials (1)

sinecatechins (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Atrophy (Phase 4)

Disease (Phase 4)

Dyspareunia (Phase 4)

Sexual Dysfunctions, Psychological (Phase 4)

Somatoform Disorders (Phase 4)

Vulvar Vestibulitis (Phase 4)

Vulvodynia (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 1
  • # of Trial APIs: 1